| Year |
Citation |
Score |
| 2023 |
Dewan KK, Caulfield A, Su Y, Sedney CJ, Callender M, Masters J, Blas-Machado U, Harvill ET. Adaptive immune protection of the middle ears differs from that of the respiratory tract. Frontiers in Cellular and Infection Microbiology. 13: 1288057. PMID 38125908 DOI: 10.3389/fcimb.2023.1288057 |
0.388 |
|
| 2023 |
Sedney CJ, Harvill ET. Making friends: active selection of symbionts and rejection of pathogens by the neonatal immune system. Frontiers in Immunology. 14: 1287518. PMID 38054002 DOI: 10.3389/fimmu.2023.1287518 |
0.317 |
|
| 2023 |
Sedney CJ, Harvill ET. The Neonatal Immune System and Respiratory Pathogens. Microorganisms. 11. PMID 37375099 DOI: 10.3390/microorganisms11061597 |
0.378 |
|
| 2023 |
Caulfield AD, Callender M, Harvill ET. Generating enhanced mucosal immunity against current challenges and new directions. Frontiers in Immunology. 14: 1126107. PMID 36895562 DOI: 10.3389/fimmu.2023.1126107 |
0.343 |
|
| 2023 |
Sedney CJ, Caulfield A, Dewan KK, Blas-Machado U, Callender M, Manley NR, Harvill ET. Novel murine model reveals an early role for pertussis toxin in disrupting neonatal immunity to . Frontiers in Immunology. 14: 1125794. PMID 36855631 DOI: 10.3389/fimmu.2023.1125794 |
0.361 |
|
| 2022 |
Ma L, Sedney C, Su Y, Dewan KK, Linz B, Harvill ET. Contribution of a Novel Pertussis Toxin-Like Factor in Mediating Persistent Otitis Media. Frontiers in Cellular and Infection Microbiology. 12: 795230. PMID 35360099 DOI: 10.3389/fcimb.2022.795230 |
0.393 |
|
| 2022 |
Soumana IH, Dewan KK, Linz B, Rivera I, Ma L, Howard LK, Caulfield AD, Sedney CJ, Blas-Machado U, Sebo P, Harvill ET. Modeling the catarrhal stage of Bordetella pertussis upper respiratory tract infections in mice. Disease Models & Mechanisms. 15. PMID 35311902 DOI: 10.1242/dmm.049266 |
0.38 |
|
| 2022 |
Gestal MC, Howard LK, Dewan KK, Harvill ET. Bbvac: A Live Vaccine Candidate That Provides Long-Lasting Anamnestic and Th17-Mediated Immunity against the Three Classical spp. Msphere. 7: e0089221. PMID 35196124 DOI: 10.1128/msphere.00892-21 |
0.442 |
|
| 2022 |
Dewan KK, Sedney C, Caulfield AD, Su Y, Ma L, Blas-Machado U, Harvill ET. Probing Immune-Mediated Clearance of Acute Middle Ear Infection in Mice. Frontiers in Cellular and Infection Microbiology. 11: 815627. PMID 35141173 DOI: 10.3389/fcimb.2021.815627 |
0.396 |
|
| 2021 |
Ma L, Dewan KK, Taylor-Mulneix DL, Wagner SM, Linz B, Rivera I, Su Y, Caulfield AD, Blas-Machado U, Harvill ET. Pertactin contributes to shedding and transmission of Bordetella bronchiseptica. Plos Pathogens. 17: e1009735. PMID 34347835 DOI: 10.1371/journal.ppat.1009735 |
0.447 |
|
| 2021 |
Soumana IH, Linz B, Dewan KK, Sarr D, Gestal MC, Howard LK, Caulfield AD, Rada B, Harvill ET. Modeling Immune Evasion and Vaccine Limitations by Targeted Nasopharyngeal Bordetella pertussis Inoculation in Mice. Emerging Infectious Diseases. 27: 2107-2116. PMID 34286682 DOI: 10.3201/eid2708.203566 |
0.424 |
|
| 2020 |
Gestal MC, Blas-Machado U, Johnson HM, Rubin LN, Dewan KK, Bryant C, Tiemeyer M, Harvill ET. Disrupting Immunosuppression Reveals a Role for Eosinophils in Coordinating the Adaptive Immune Response in the Respiratory Tract. Microorganisms. 8. PMID 33212993 DOI: 10.3390/microorganisms8111808 |
0.404 |
|
| 2020 |
Damron FH, Barbier M, Dubey P, Edwards KM, Gu XX, Klein NP, Lu K, Mills KHG, Pasetti MF, Read RC, Rohani P, Sebo P, Harvill ET. Overcoming Waning Immunity in Pertussis Vaccines: Workshop of the National Institute of Allergy and Infectious Diseases. Journal of Immunology (Baltimore, Md. : 1950). 205: 877-882. PMID 32769142 DOI: 10.4049/Jimmunol.2000676 |
0.354 |
|
| 2020 |
Locht C, Carbonetti NH, Cherry JD, Damron FH, Edwards KM, Fernandez R, Harvill ET, Hozbor D, Mills KHG, Rodriguez ME, Mascart F. Highlights of the 12th International Bordetella Symposium. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32463883 DOI: 10.1093/Cid/Ciaa651 |
0.373 |
|
| 2020 |
Dewan KK, Linz B, DeRocco SE, Harvill ET. Acellular Pertussis Vaccine Components: Today and Tomorrow. Vaccines. 8. PMID 32414005 DOI: 10.3390/Vaccines8020217 |
0.338 |
|
| 2019 |
Gestal MC, Johnson HM, Harvill ET. Immunomodulation as a Novel Strategy for Prevention and Treatment of spp. Infections. Frontiers in Immunology. 10: 2869. PMID 31921136 DOI: 10.3389/Fimmu.2019.02869 |
0.48 |
|
| 2019 |
Rivera I, Linz B, Dewan KK, Ma L, Rice CA, Kyle DE, Harvill ET. Conservation of Ancient Genetic Pathways for Intracellular Persistence Among Animal Pathogenic Bordetellae. Frontiers in Microbiology. 10: 2839. PMID 31921025 DOI: 10.3389/Fmicb.2019.02839 |
0.383 |
|
| 2019 |
Gestal MC, Howard LK, Dewan K, Johnson HM, Barbier M, Bryant C, Soumana IH, Rivera I, Linz B, Blas-Machado U, Harvill ET. Enhancement of immune response against Bordetella spp. by disrupting immunomodulation. Scientific Reports. 9: 20261. PMID 31889098 DOI: 10.1038/S41598-019-56652-Z |
0.571 |
|
| 2019 |
Belhart K, Gutierrez MP, Zacca F, Ambrosis N, Cartelle Gestal M, Taylor D, Dahlstrom KM, Harvill ET, O'Toole GA, Sisti F, Fernández J. diguanylate cyclase BdcA regulates motility and is important for the establishment of respiratory infection in mice. Journal of Bacteriology. PMID 31209073 DOI: 10.1128/Jb.00011-19 |
0.391 |
|
| 2019 |
Dewan KK, Taylor-Mulneix DL, Campos LL, Skarlupka AL, Wagner SM, Ryman VE, Gestal MC, Ma L, Blas-Machado U, Faddis BT, Harvill ET. A model of chronic, transmissible Otitis Media in mice. Plos Pathogens. 15: e1007696. PMID 30970038 DOI: 10.1371/Journal.Ppat.1007696 |
0.454 |
|
| 2019 |
Dewan KK, Harvill ET. Did new transmission cycles in anthropogenic, dense, host populations encourage the emergence and speciation of pathogenic Bordetella? Plos Pathogens. 15: e1007600. PMID 30921446 DOI: 10.1371/Journal.Ppat.1007600 |
0.337 |
|
| 2019 |
Linz B, Ma L, Rivera I, Harvill ET. Genotypic and phenotypic adaptation of pathogens: lesson from the genus Bordetella. Current Opinion in Infectious Diseases. PMID 30921085 DOI: 10.1097/Qco.0000000000000549 |
0.341 |
|
| 2018 |
Gestal MC, Whitesides LT, Harvill ET. Integrated Signaling Pathways Mediate Bordetella Immunomodulation, Persistence, and Transmission. Trends in Microbiology. 27: 118-130. PMID 30661570 DOI: 10.1016/J.Tim.2018.09.010 |
0.47 |
|
| 2018 |
Linz B, Mukhtar N, Shabbir MZ, Rivera I, Ivanov YV, Tahir Z, Yaqub T, Harvill ET. Virulent Epidemic Pneumonia in Sheep Caused by the Human Pathogen . Frontiers in Microbiology. 9: 2616. PMID 30459734 DOI: 10.3389/Fmicb.2018.02616 |
0.424 |
|
| 2018 |
Gestal MC, Rivera I, Howard LK, Dewan KK, Soumana IH, Dedloff M, Nicholson TL, Linz B, Harvill ET. Blood or Serum Exposure Induce Global Transcriptional Changes, Altered Antigenic Profile, and Increased Cytotoxicity by Classical Bordetellae. Frontiers in Microbiology. 9: 1969. PMID 30245672 DOI: 10.3389/Fmicb.2018.01969 |
0.332 |
|
| 2018 |
Dewan KK, Skarlupka AL, Rivera I, Cuff LE, Gestal MC, Taylor-Mulneix DL, Wagner S, Ryman VE, Rodriguez C, Hamidou Soumana I, Levin BR, Harvill ET. Development of macrolide resistance in Bordetella bronchiseptica is associated with the loss of virulence. The Journal of Antimicrobial Chemotherapy. PMID 30107601 DOI: 10.1093/Jac/Dky264 |
0.306 |
|
| 2017 |
Taylor-Mulneix DL, Hamidou Soumana I, Linz B, Harvill ET. Evolution of Bordetellae from Environmental Microbes to Human Respiratory Pathogens: Amoebae as a Missing Link. Frontiers in Cellular and Infection Microbiology. 7: 510. PMID 29322035 DOI: 10.3389/Fcimb.2017.00510 |
0.434 |
|
| 2017 |
Freyberg Z, Harvill ET. Pathogen manipulation of host metabolism: A common strategy for immune evasion. Plos Pathogens. 13: e1006669. PMID 29216326 DOI: 10.1371/Journal.Ppat.1006669 |
0.415 |
|
| 2017 |
Dewan KK, Taylor-Mulneix DL, Hilburger LJ, Rivera I, Preston A, Harvill ET. An Extracellular Polysaccharide Locus Required for Transmission of Bordetella bronchiseptica. The Journal of Infectious Diseases. PMID 28973366 DOI: 10.1093/Infdis/Jix251 |
0.38 |
|
| 2017 |
Taylor-Mulneix DL, Bendor L, Linz B, Rivera I, Ryman VE, Dewan KK, Wagner SM, Wilson EF, Hilburger LJ, Cuff LE, West CM, Harvill ET. Bordetella bronchiseptica exploits the complex life cycle of Dictyostelium discoideum as an amplifying transmission vector. Plos Biology. 15: e2000420. PMID 28403138 DOI: 10.1371/Journal.Pbio.2000420 |
0.431 |
|
| 2017 |
Hamidou Soumana I, Linz B, Harvill ET. Environmental Origin of the Genus Bordetella. Frontiers in Microbiology. 8: 28. PMID 28174558 DOI: 10.3389/Fmicb.2017.00028 |
0.341 |
|
| 2017 |
Gorgojo J, Scharrig E, Gómez RM, Harvill ET, Rodríguez ME. Bordetella parapertussis Circumvents Neutrophil Extracellular Bactericidal Mechanisms. Plos One. 12: e0169936. PMID 28095485 DOI: 10.1371/Journal.Pone.0169936 |
0.465 |
|
| 2016 |
Linz B, Ivanov YV, Preston A, Brinkac L, Parkhill J, Kim M, Harris SR, Goodfield LL, Fry NK, Gorringe AR, Nicholson TL, Register KB, Losada L, Harvill ET. Acquisition and loss of virulence-associated factors during genome evolution and speciation in three clades of Bordetella species. Bmc Genomics. 17: 767. PMID 27716057 DOI: 10.1186/S12864-016-3112-5 |
0.333 |
|
| 2016 |
Ivanov YV, Linz B, Register KB, Newman JD, Taylor DL, Boschert KR, Le Guyon S, Wilson EF, Brinkac LM, Sanka R, Greco SC, Klender PM, Losada L, Harvill ET. Identification and taxonomic characterization of Bordetella pseudohinzii sp. nov. isolated from laboratory-raised mice. International Journal of Systematic and Evolutionary Microbiology. PMID 27707434 DOI: 10.1099/Ijsem.0.001540 |
0.455 |
|
| 2015 |
Nguyen AW, Wagner EK, Laber JR, Goodfield LL, Smallridge WE, Harvill ET, Papin JF, Wolf RF, Padlan EA, Bristol A, Kaleko M, Maynard JA. A cocktail of humanized anti-pertussis toxin antibodies limits disease in murine and baboon models of whooping cough. Science Translational Medicine. 7: 316ra195. PMID 26631634 DOI: 10.1126/Scitranslmed.Aad0966 |
0.364 |
|
| 2015 |
Bendor L, Weyrich LS, Linz B, Rolin OY, Taylor DL, Goodfield LL, Smallridge WE, Kennett MJ, Harvill ET. Type Six Secretion System of Bordetella bronchiseptica and Adaptive Immune Components Limit Intracellular Survival During Infection. Plos One. 10: e0140743. PMID 26485303 DOI: 10.1371/Journal.Pone.0140743 |
0.836 |
|
| 2015 |
Park J, Zhang Y, Chen C, Dudley EG, Harvill ET. Diversity of secretion systems associated with virulence characteristics of the classical bordetellae. Microbiology (Reading, England). 161: 2328-40. PMID 26459829 DOI: 10.1099/Mic.0.000197 |
0.423 |
|
| 2015 |
Bolotin S, Harvill ET, Crowcroft NS. What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine. Pathogens and Disease. 73: ftv057. PMID 26253079 DOI: 10.1093/Femspd/Ftv057 |
0.336 |
|
| 2015 |
Hester SE, Goodfield LL, Park J, Feaga HA, Ivanov YV, Bendor L, Taylor DL, Harvill ET. Host Specificity of Ovine Bordetella parapertussis and the Role of Complement. Plos One. 10: e0130964. PMID 26158540 DOI: 10.1371/Journal.Pone.0130964 |
0.688 |
|
| 2015 |
Register KB, Ivanov YV, Jacobs N, Meyer JA, Goodfield LL, Muse SJ, Smallridge WE, Brinkac L, Kim M, Sanka R, Harvill ET, Losada L. Draft Genome Sequences of 53 Genetically Distinct Isolates of Bordetella bronchiseptica Representing 11 Terrestrial and Aquatic Hosts. Genome Announcements. 3. PMID 25908122 DOI: 10.1128/Genomea.00152-15 |
0.402 |
|
| 2015 |
Register KB, Ivanov YV, Harvill ET, Brinkac L, Kim M, Losada L. Draft Genome Sequences of Six Bordetella hinzii Isolates Acquired from Avian and Mammalian Hosts. Genome Announcements. 3. PMID 25792043 DOI: 10.1128/Genomea.00081-15 |
0.395 |
|
| 2015 |
Shabbir MZ, Malys T, Ivanov YV, Park J, Shabbir MA, Rabbani M, Yaqub T, Harvill ET. Microbial communities present in the lower respiratory tract of clinically healthy birds in Pakistan. Poultry Science. 94: 612-20. PMID 25667427 DOI: 10.3382/Ps/Pev010 |
0.371 |
|
| 2015 |
Register KB, Ivanov YV, Harvill ET, Davison N, Foster G. Novel, host-restricted genotypes of Bordetella bronchiseptica associated with phocine respiratory tract isolates. Microbiology (Reading, England). 161: 580-92. PMID 25627438 DOI: 10.1099/Mic.0.000035 |
0.349 |
|
| 2014 |
Gorgojo J, Harvill ET, RodrÃguez ME. Bordetella parapertussis survives inside human macrophages in lipid raft-enriched phagosomes. Infection and Immunity. 82: 5175-84. PMID 25267839 DOI: 10.1128/Iai.02553-14 |
0.505 |
|
| 2014 |
Place DE, Muse SJ, Kirimanjeswara GS, Harvill ET. Caspase-1-independent interleukin-1β is required for clearance of Bordetella pertussis infections and whole-cell vaccine-mediated immunity. Plos One. 9: e107188. PMID 25198773 DOI: 10.1371/Journal.Pone.0107188 |
0.743 |
|
| 2014 |
Harvill ET, Goodfield LL, Ivanov Y, Smallridge WE, Meyer JA, Cassiday PK, Tondella ML, Brinkac L, Sanka R, Kim M, Losada L. Genome Sequences of Nine Bordetella holmesii Strains Isolated in the United States. Genome Announcements. 2. PMID 24948754 DOI: 10.1128/Genomea.00438-14 |
0.363 |
|
| 2014 |
Bart MJ, Harris SR, Advani A, Arakawa Y, Bottero D, Bouchez V, Cassiday PK, Chiang CS, Dalby T, Fry NK, Gaillard ME, van Gent M, Guiso N, Hallander HO, Harvill ET, et al. Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. Mbio. 5: e01074. PMID 24757216 DOI: 10.1128/Mbio.01074-14 |
0.421 |
|
| 2014 |
Hewlett EL, Burns DL, Cotter PA, Harvill ET, Merkel TJ, Quinn CP, Stibitz ES. Pertussis pathogenesis--what we know and what we don't know. The Journal of Infectious Diseases. 209: 982-5. PMID 24626533 DOI: 10.1093/Infdis/Jit639 |
0.371 |
|
| 2014 |
Rolin O, Smallridge W, Henry M, Goodfield L, Place D, Harvill ET. Toll-like receptor 4 limits transmission of Bordetella bronchiseptica. Plos One. 9: e85229. PMID 24497924 DOI: 10.1371/Journal.Pone.0085229 |
0.832 |
|
| 2014 |
Rolin O, Muse SJ, Safi C, Elahi S, Gerdts V, Hittle LE, Ernst RK, Harvill ET, Preston A. Enzymatic modification of lipid A by ArnT protects Bordetella bronchiseptica against cationic peptides and is required for transmission. Infection and Immunity. 82: 491-9. PMID 24478065 DOI: 10.1128/Iai.01260-12 |
0.817 |
|
| 2014 |
Smallridge WE, Rolin OY, Jacobs NT, Harvill ET. Different effects of whole-cell and acellular vaccines on Bordetella transmission. The Journal of Infectious Diseases. 209: 1981-8. PMID 24443545 DOI: 10.1093/Infdis/Jiu030 |
0.788 |
|
| 2014 |
Weyrich LS, Feaga HA, Park J, Muse SJ, Safi CY, Rolin OY, Young SE, Harvill ET. Resident microbiota affect Bordetella pertussis infectious dose and host specificity. The Journal of Infectious Diseases. 209: 913-21. PMID 24227794 DOI: 10.1093/Infdis/Jit597 |
0.823 |
|
| 2013 |
Harvill ET, Goodfield LL, Ivanov Y, Meyer JA, Newth C, Cassiday P, Tondella ML, Liao P, Zimmerman J, Meert K, Wessel D, Berger J, Dean JM, Holubkov R, Burr J, et al. Genome Sequences of 28 Bordetella pertussis U.S. Outbreak Strains Dating from 2010 to 2012. Genome Announcements. 1. PMID 24356839 DOI: 10.1128/Genomea.01075-13 |
0.387 |
|
| 2013 |
Hester SE, Park J, Goodfield LL, Feaga HA, Preston A, Harvill ET. Horizontally acquired divergent O-antigen contributes to escape from cross-immunity in the classical bordetellae. Bmc Evolutionary Biology. 13: 209. PMID 24067113 DOI: 10.1186/1471-2148-13-209 |
0.6 |
|
| 2013 |
Harvill ET. Cultivating our "frienemies": viewing immunity as microbiome management. Mbio. 4. PMID 23532974 DOI: 10.1128/Mbio.00027-13 |
0.365 |
|
| 2013 |
Weyrich LS, Harvill ET. Teaching ethical aptitude to graduate student researchers. Accountability in Research. 20: 5-12. PMID 23281581 DOI: 10.1080/08989621.2013.749742 |
0.561 |
|
| 2013 |
Lass S, Hudson PJ, Thakar J, Saric J, Harvill E, Albert R, Perkins SE. Generating super-shedders: co-infection increases bacterial load and egg production of a gastrointestinal helminth. Journal of the Royal Society, Interface / the Royal Society. 10: 20120588. PMID 23256186 DOI: 10.1098/Rsif.2012.0588 |
0.43 |
|
| 2012 |
Hester SE, Lui M, Nicholson T, Nowacki D, Harvill ET. Identification of a CO2 responsive regulon in Bordetella. Plos One. 7: e47635. PMID 23112828 DOI: 10.1371/Journal.Pone.0047635 |
0.657 |
|
| 2012 |
Zhang X, Weyrich LS, Lavine JS, Karanikas AT, Harvill ET. Lack of cross-protection against Bordetella holmesii after pertussis vaccination. Emerging Infectious Diseases. 18: 1771-9. PMID 23092514 DOI: 10.3201/Eid1811.111544 |
0.699 |
|
| 2012 |
Weyrich LS, Rolin OY, Muse SJ, Park J, Spidale N, Kennett MJ, Hester SE, Chen C, Dudley EG, Harvill ET. A Type VI secretion system encoding locus is required for Bordetella bronchiseptica immunomodulation and persistence in vivo. Plos One. 7: e45892. PMID 23071529 DOI: 10.1371/Journal.Pone.0045892 |
0.807 |
|
| 2012 |
Park J, Zhang Y, Buboltz AM, Zhang X, Schuster SC, Ahuja U, Liu M, Miller JF, Sebaihia M, Bentley SD, Parkhill J, Harvill ET. Comparative genomics of the classical Bordetella subspecies: the evolution and exchange of virulence-associated diversity amongst closely related pathogens. Bmc Genomics. 13: 545. PMID 23051057 DOI: 10.1186/1471-2164-13-545 |
0.784 |
|
| 2012 |
Gorgojo J, Lamberti Y, Valdez H, Harvill ET, Rodríguez ME. Bordetella parapertussis survives the innate interaction with human neutrophils by impairing bactericidal trafficking inside the cell through a lipid raft-dependent mechanism mediated by the lipopolysaccharide O antigen. Infection and Immunity. 80: 4309-16. PMID 23027528 DOI: 10.1128/Iai.00662-12 |
0.507 |
|
| 2012 |
Barchinger SE, Zhang X, Hester SE, Rodriguez ME, Harvill ET, Ades SE. sigE facilitates the adaptation of Bordetella bronchiseptica to stress conditions and lethal infection in immunocompromised mice. Bmc Microbiology. 12: 179. PMID 22897969 DOI: 10.1186/1471-2180-12-179 |
0.689 |
|
| 2012 |
Ahuja U, Liu M, Tomida S, Park J, Souda P, Whitelegge J, Li H, Harvill ET, Parkhill J, Miller JF. Phenotypic and genomic analysis of hypervirulent human-associated Bordetella bronchiseptica. Bmc Microbiology. 12: 167. PMID 22863321 DOI: 10.1186/1471-2180-12-167 |
0.396 |
|
| 2011 |
Zhang X, Goel T, Goodfield LL, Muse SJ, Harvill ET. Decreased leukocyte accumulation and delayed Bordetella pertussis clearance in IL-6-/- mice. Journal of Immunology (Baltimore, Md. : 1950). 186: 4895-904. PMID 21398615 DOI: 10.4049/Jimmunol.1000594 |
0.47 |
|
| 2011 |
Zhang X, Hester SE, Kennett MJ, Karanikas AT, Bendor L, Place DE, Harvill ET. Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis. Infection and Immunity. 79: 527-41. PMID 20974829 DOI: 10.1128/Iai.00590-10 |
0.635 |
|
| 2011 |
Pathak AK, Boag B, Poss M, Harvill ET, Cattadori IM. Seasonal breeding drives the incidence of a chronic bacterial infection in a free-living herbivore population. Epidemiology and Infection. 139: 1210-9. PMID 20943004 DOI: 10.1017/S0950268810002311 |
0.396 |
|
| 2010 |
Long GH, Sinha D, Read AF, Pritt S, Kline B, Harvill ET, Hudson PJ, Bjørnstad ON. Identifying the age cohort responsible for transmission in a natural outbreak of Bordetella bronchiseptica. Plos Pathogens. 6: e1001224. PMID 21187891 DOI: 10.1371/Journal.Ppat.1001224 |
0.382 |
|
| 2010 |
Lavine J, Broutin H, Harvill ET, Bjørnstad ON. Imperfect vaccine-induced immunity and whooping cough transmission to infants. Vaccine. 29: 11-6. PMID 21034823 DOI: 10.1016/J.Vaccine.2010.10.029 |
0.411 |
|
| 2010 |
Vinogradov E, King JD, Pathak AK, Harvill ET, Preston A. Antigenic Variation among Bordetella: Bordetella bronchiseptica strain MO149 expresses a novel o chain that is poorly immunogenic. The Journal of Biological Chemistry. 285: 26869-77. PMID 20592026 DOI: 10.1074/Jbc.M110.115121 |
0.334 |
|
| 2010 |
Long GH, Karanikas AT, Harvill ET, Read AF, Hudson PJ. Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis. Proceedings. Biological Sciences / the Royal Society. 277: 2017-25. PMID 20200027 DOI: 10.1098/Rspb.2010.0010 |
0.451 |
|
| 2010 |
Lamberti YA, Hayes JA, Perez Vidakovics ML, Harvill ET, Rodriguez ME. Intracellular trafficking of Bordetella pertussis in human macrophages. Infection and Immunity. 78: 907-13. PMID 20065021 DOI: 10.1128/Iai.01031-09 |
0.453 |
|
| 2010 |
Wolfe DN, Karanikas AT, Hester SE, Kennett MJ, Harvill ET. IL-10 induction by Bordetella parapertussis limits a protective IFN-gamma response. Journal of Immunology (Baltimore, Md. : 1950). 184: 1392-400. PMID 20042578 DOI: 10.4049/Jimmunol.0803045 |
0.667 |
|
| 2009 |
Zhang X, Rodríguez ME, Harvill ET. O antigen allows B. parapertussis to evade B. pertussis vaccine-induced immunity by blocking binding and functions of cross-reactive antibodies. Plos One. 4: e6989. PMID 19750010 DOI: 10.1371/Journal.Pone.0006989 |
0.476 |
|
| 2009 |
Zhang X, Goebel EM, Rodríguez ME, Preston A, Harvill ET. The O antigen is a critical antigen for the development of a protective immune response to Bordetella parapertussis. Infection and Immunity. 77: 5050-8. PMID 19737902 DOI: 10.1128/Iai.00667-09 |
0.468 |
|
| 2009 |
Goebel EM, Zhang X, Harvill ET. Bordetella pertussis infection or vaccination substantially protects mice against B. bronchiseptica infection. Plos One. 4: e6778. PMID 19707559 DOI: 10.1371/Journal.Pone.0006778 |
0.534 |
|
| 2009 |
Nicholson TL, Buboltz AM, Harvill ET, Brockmeier SL. Microarray and functional analysis of growth phase-dependent gene regulation in Bordetella bronchiseptica. Infection and Immunity. 77: 4221-31. PMID 19667046 DOI: 10.1128/Iai.00136-09 |
0.764 |
|
| 2009 |
Buboltz AM, Nicholson TL, Weyrich LS, Harvill ET. Role of the type III secretion system in a hypervirulent lineage of Bordetella bronchiseptica. Infection and Immunity. 77: 3969-77. PMID 19596779 DOI: 10.1128/Iai.01362-08 |
0.786 |
|
| 2009 |
Buboltz AM, Nicholson TL, Karanikas AT, Preston A, Harvill ET. Evidence for horizontal gene transfer of two antigenically distinct O antigens in Bordetella bronchiseptica. Infection and Immunity. 77: 3249-57. PMID 19528223 DOI: 10.1128/Iai.01448-08 |
0.787 |
|
| 2009 |
King AA, Shrestha S, Harvill ET, Bjørnstad ON. Evolution of acute infections and the invasion-persistence trade-off. The American Naturalist. 173: 446-55. PMID 19231966 DOI: 10.1086/597217 |
0.424 |
|
| 2009 |
Wolfe DN, Buboltz AM, Harvill ET. Inefficient Toll-like receptor-4 stimulation enables Bordetella parapertussis to avoid host immunity. Plos One. 4: e4280. PMID 19169359 DOI: 10.1371/Journal.Pone.0004280 |
0.832 |
|
| 2009 |
Thakar J, Saadatpour-Moghaddam A, Harvill ET, Albert R. Constraint-based network model of pathogen-immune system interactions. Journal of the Royal Society, Interface / the Royal Society. 6: 599-612. PMID 18952547 DOI: 10.1098/Rsif.2008.0363 |
0.411 |
|
| 2009 |
Restif O, Thakar J, Harvill ET. Analysis with mathematical models provides insights into infectious diseases Microbe. 4: 176-182. DOI: 10.1128/Microbe.4.176.1 |
0.336 |
|
| 2008 |
Buboltz AM, Nicholson TL, Parette MR, Hester SE, Parkhill J, Harvill ET. Replacement of adenylate cyclase toxin in a lineage of Bordetella bronchiseptica. Journal of Bacteriology. 190: 5502-11. PMID 18556799 DOI: 10.1128/Jb.00226-08 |
0.795 |
|
| 2008 |
Harvill ET, Osorio M, Loving CL, Lee GM, Kelly VK, Merkel TJ. Anamnestic protective immunity to Bacillus anthracis is antibody mediated but independent of complement and Fc receptors Infection and Immunity. 76: 2177-2182. PMID 18316379 DOI: 10.1128/Iai.00647-07 |
0.525 |
|
| 2008 |
Goebel EM, Wolfe DN, Elder K, Stibitz S, Harvill ET. O antigen protects Bordetella parapertussis from complement. Infection and Immunity. 76: 1774-80. PMID 18285500 DOI: 10.1128/Iai.01629-07 |
0.462 |
|
| 2008 |
Restif O, Wolfe DN, Goebel EM, Bjornstad ON, Harvill ET. Of mice and men: Asymmetric interactions between Bordetella pathogen species Parasitology. 135: 1517-1529. PMID 18261255 DOI: 10.1017/S0031182008000279 |
0.542 |
|
| 2007 |
MacArthur I, Mann PB, Harvill ET, Preston A. IEIIS Meeting minireview: Bordetella evolution: lipid A and Toll-like receptor 4. Journal of Endotoxin Research. 13: 243-7. PMID 17956943 DOI: 10.1177/0968051907082609 |
0.405 |
|
| 2007 |
Wolfe DN, Mann PB, Buboltz AM, Harvill ET. Delayed role of tumor necrosis factor- alpha in overcoming the effects of pertussis toxin. The Journal of Infectious Diseases. 196: 1228-36. PMID 17955442 DOI: 10.1086/521303 |
0.808 |
|
| 2007 |
Wolfe DN, Goebel EM, Bjornstad ON, Restif O, Harvill ET. The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity. Infection and Immunity. 75: 4972-9. PMID 17698566 DOI: 10.1128/Iai.00763-07 |
0.551 |
|
| 2007 |
Wolfe DN, Kirimanjeswara GS, Goebel EM, Harvill ET. Comparative role of immunoglobulin A in protective immunity against the Bordetellae. Infection and Immunity. 75: 4416-22. PMID 17591791 DOI: 10.1128/Iai.00412-07 |
0.79 |
|
| 2007 |
Thakar J, Pilione M, Kirimanjeswara G, Harvill ET, Albert R. Modeling systems-level regulation of host immune responses. Plos Computational Biology. 3: e109. PMID 17559300 DOI: 10.1371/Journal.Pcbi.0030109 |
0.812 |
|
| 2007 |
Mann P, Goebel E, Barbarich J, Pilione M, Kennett M, Harvill E. Use of a genetically defined double mutant strain of Bordetella bronchiseptica lacking adenylate cyclase and type III secretion as a live vaccine. Infection and Immunity. 75: 3665-72. PMID 17452472 DOI: 10.1128/Iai.01648-06 |
0.818 |
|
| 2007 |
Gopinathan L, Kirimanjeswara GS, Wolfe DN, Kelley ML, Harvill ET. Different mechanisms of vaccine-induced and infection-induced immunity to Bordetella bronchiseptica. Microbes and Infection / Institut Pasteur. 9: 442-8. PMID 17317263 DOI: 10.1016/J.Micinf.2007.01.001 |
0.748 |
|
| 2007 |
Joo J, Harvill E, Albert R. Effects of noise on ecological invasion processes: Bacteriophage-mediated competition in bacteria Journal of Statistical Physics. 128: 229-256. DOI: 10.1007/S10955-006-9182-Z |
0.398 |
|
| 2006 |
Joo J, Gunny M, Cases M, Hudson P, Albert R, Harvill E. Bacteriophage-mediated competition in Bordetella bacteria. Proceedings. Biological Sciences / the Royal Society. 273: 1843-8. PMID 16790419 DOI: 10.1098/Rspb.2006.3512 |
0.421 |
|
| 2006 |
Pilione MR, Agosto LM, Kennett MJ, Harvill ET. CD11b is required for the resolution of inflammation induced by Bordetella bronchiseptica respiratory infection. Cellular Microbiology. 8: 758-68. PMID 16611225 DOI: 10.1111/J.1462-5822.2005.00663.X |
0.838 |
|
| 2006 |
Pilione MR, Harvill ET. The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance. Infection and Immunity. 74: 1043-9. PMID 16428751 DOI: 10.1128/Iai.74.2.1043-1049.2006 |
0.818 |
|
| 2005 |
Kirimanjeswara GS, Mann PB, Pilione M, Kennett MJ, Harvill ET. The complex mechanism of antibody-mediated clearance of Bordetella from the lungs requires TLR4. Journal of Immunology (Baltimore, Md. : 1950). 175: 7504-11. PMID 16301658 DOI: 10.4049/Jimmunol.175.11.7504 |
0.813 |
|
| 2005 |
Mann PB, Wolfe D, Latz E, Golenbock D, Preston A, Harvill ET. Comparative toll-like receptor 4-mediated innate host defense to Bordetella infection. Infection and Immunity. 73: 8144-52. PMID 16299309 DOI: 10.1128/Iai.73.12.8144-8152.2005 |
0.483 |
|
| 2005 |
Kirimanjeswara GS, Agosto LM, Kennett MJ, Bjornstad ON, Harvill ET. Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis. The Journal of Clinical Investigation. 115: 3594-601. PMID 16294220 DOI: 10.1172/Jci24609 |
0.768 |
|
| 2005 |
Hughes MA, Green CS, Lowchyj L, Lee GM, Grippe VK, Smith MF, Huang LY, Harvill ET, Merkel TJ. MyD88-dependent signaling contributes to protection following Bacillus anthracis spore challenge of mice: Implications for toll-like receptor signaling Infection and Immunity. 73: 7535-7540. PMID 16239556 DOI: 10.1128/Iai.73.11.7535-7540.2005 |
0.482 |
|
| 2005 |
Wolfe DN, Kirimanjeswara GS, Harvill ET. Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity. Infection and Immunity. 73: 6508-13. PMID 16177324 DOI: 10.1128/Iai.73.10.6508-6513.2005 |
0.78 |
|
| 2005 |
Skinner JA, Pilione MR, Shen H, Harvill ET, Yuk MH. Bordetella type III secretion modulates dendritic cell migration resulting in immunosuppression and bacterial persistence. Journal of Immunology (Baltimore, Md. : 1950). 175: 4647-52. PMID 16177111 DOI: 10.4049/Jimmunol.175.7.4647 |
0.83 |
|
| 2005 |
Bjørnstad ON, Harvill ET. Evolution and emergence of Bordetella in humans. Trends in Microbiology. 13: 355-9. PMID 15990312 DOI: 10.1016/J.Tim.2005.06.007 |
0.444 |
|
| 2005 |
Harvill ET, Lee G, Grippe VK, Merkel TJ. Complement depletion renders C57BL/6 mice sensitive to the Bacillus anthracis sterne strain Infection and Immunity. 73: 4420-4422. PMID 15972541 DOI: 10.1128/Iai.73.7.4420-4422.2005 |
0.374 |
|
| 2004 |
Mann PB, Elder KD, Kennett MJ, Harvill ET. Toll-like receptor 4-dependent early elicited tumor necrosis factor alpha expression is critical for innate host defense against Bordetella bronchiseptica. Infection and Immunity. 72: 6650-8. PMID 15501798 DOI: 10.1128/Iai.72.11.6650-6658.2004 |
0.445 |
|
| 2004 |
Elder KD, Harvill ET. Strain-dependent role of BrkA during Bordetella pertussis infection of the murine respiratory tract. Infection and Immunity. 72: 5919-24. PMID 15385494 DOI: 10.1128/Iai.72.10.5919-5924.2004 |
0.48 |
|
| 2004 |
Pilione MR, Pishko EJ, Preston A, Maskell DJ, Harvill ET. pagP is required for resistance to antibody-mediated complement lysis during Bordetella bronchiseptica respiratory infection. Infection and Immunity. 72: 2837-42. PMID 15102794 DOI: 10.1128/Iai.72.5.2837-2842.2004 |
0.841 |
|
| 2004 |
Mann PB, Kennett MJ, Harvill ET. Toll-like receptor 4 is critical to innate host defense in a murine model of bordetellosis. The Journal of Infectious Diseases. 189: 833-6. PMID 14976600 DOI: 10.1086/381898 |
0.503 |
|
| 2004 |
Liu M, Gingery M, Doulatov SR, Liu Y, Hodes A, Baker S, Davis P, Simmonds M, Churcher C, Mungall K, Quail MA, Preston A, Harvill ET, Maskell DJ, Eiserling FA, et al. Genomic and genetic analysis of Bordetella bacteriophages encoding reverse transcriptase-mediated tropism-switching cassettes. Journal of Bacteriology. 186: 1503-17. PMID 14973019 DOI: 10.1128/Jb.186.5.1503-1517.2004 |
0.319 |
|
| 2004 |
Pishko EJ, Kirimanjeswara GS, Pilione MR, Gopinathan L, Kennett MJ, Harvill ET. Antibody-mediated bacterial clearance from the lower respiratory tract of mice requires complement component C3. European Journal of Immunology. 34: 184-93. PMID 14971044 DOI: 10.1002/Eji.200324234 |
0.814 |
|
| 2003 |
Rodriguez ME, Van der Pol WL, Kirimanjeswara GS, Mann PB, Harvill ET. Humoral Immunity against Bordetella pertussis: Antibodies or B Cells? Infection and Immunity. 71: 6686. PMID 14573698 DOI: 10.1128/IAI.71.11.6686.2003 |
0.712 |
|
| 2003 |
Pishko EJ, Betting DJ, Hutter CS, Harvill ET. Bordetella pertussis acquires resistance to complement-mediated killing in vivo. Infection and Immunity. 71: 4936-42. PMID 12933835 DOI: 10.1128/Iai.71.9.4936-4942.2003 |
0.427 |
|
| 2003 |
Preston A, Maxim E, Toland E, Pishko EJ, Harvill ET, Caroff M, Maskell DJ. Bordetella bronchiseptica PagP is a Bvg-regulated lipid A palmitoyl transferase that is required for persistent colonization of the mouse respiratory tract. Molecular Microbiology. 48: 725-36. PMID 12694617 DOI: 10.1046/J.1365-2958.2003.03484.X |
0.368 |
|
| 2003 |
Kirimanjeswara GS, Mann PB, Harvill ET. Role of antibodies in immunity to Bordetella infections. Infection and Immunity. 71: 1719-24. PMID 12654784 DOI: 10.1128/Iai.71.4.1719-1724.2003 |
0.778 |
|
| 2003 |
Burns VC, Pishko EJ, Preston A, Maskell DJ, Harvill ET. Role of Bordetella O antigen in respiratory tract infection. Infection and Immunity. 71: 86-94. PMID 12496152 DOI: 10.1128/Iai.71.1.86-94.2003 |
0.48 |
|
| 2002 |
Heininger U, Cotter PA, Fescemyer HW, Martinez de Tejada G, Yuk MH, Miller JF, Harvill ET. Comparative phenotypic analysis of the Bordetella parapertussis isolate chosen for genomic sequencing. Infection and Immunity. 70: 3777-84. PMID 12065521 DOI: 10.1128/Iai.70.7.3777-3784.2002 |
0.417 |
|
| 2001 |
Le LQ, Kabarowski JH, Weng Z, Satterthwaite AB, Harvill ET, Jensen ER, Miller JF, Witte ON. Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome. Immunity. 14: 561-71. PMID 11371358 DOI: 10.1016/S1074-7613(01)00145-5 |
0.321 |
|
| 2000 |
Harvill ET, Preston A, Cotter PA, Allen AG, Maskell DJ, Miller JF. Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection. Infection and Immunity. 68: 6720-8. PMID 11083787 DOI: 10.1128/Iai.68.12.6720-6728.2000 |
0.502 |
|
| 2000 |
Ming Huam Y, Harvill ET, Cotter PA, Miller JF. Modulation of host immune responses, induction of apoptosis and inhibition of NF-κB activation by the Bordetella type III secretion system Molecular Microbiology. 35: 991-1004. PMID 10712682 DOI: 10.1046/J.1365-2958.2000.01785.X |
0.514 |
|
| 2000 |
Harvill ET, Miller JF. Manipulating the host to study bacterial virulence Current Opinion in Microbiology. 3: 93-96. PMID 10679424 DOI: 10.1016/S1369-5274(99)00057-0 |
0.479 |
|
| 1999 |
Harvill ET, Cotter PA, Miller JF. Pregenomic comparative analysis between Bordetella bronchiseptica RB50 and Bordetella pertussis Tohama I in murine models of respiratory tract infection Infection and Immunity. 67: 6109-6118. PMID 10531274 DOI: 10.1128/Iai.67.11.6109-6118.1999 |
0.534 |
|
| 1999 |
Harvill ET, Cotter PA, Yuk MH, Miller JF. Probing the function of Bordetella bronchiseptica adenylate cyclase toxin by manipulating host immunity Infection and Immunity. 67: 1493-1500. PMID 10024599 DOI: 10.1128/Iai.67.3.1493-1500.1999 |
0.534 |
|
| 1998 |
Penichet ML, Harvill ET, Morrison SL. An IgG3-IL-2 fusion protein recognizing a murine B cell lymphoma exhibits effective tumor imaging and antitumor activity Journal of Interferon and Cytokine Research. 18: 597-607. PMID 9726441 DOI: 10.1089/Jir.1998.18.597 |
0.527 |
|
| 1998 |
Yuk MH, Harvill ET, Miller JF. The BvgAS virulence control system regulates type III secretion in Bordetella bronchiseptica Molecular Microbiology. 28: 945-959. PMID 9663681 DOI: 10.1046/J.1365-2958.1998.00850.X |
0.468 |
|
| 1997 |
Penichet ML, Harvill ET, Morrison SL. Antibody-IL-2 fusion proteins: A novel strategy for immune potentiation Human Antibodies. 8: 106-118. PMID 9322080 DOI: 10.3233/Hab-1997-8301 |
0.562 |
|
| 1997 |
Sensel MG, Josefina Coloma M, Harvill ET, Shin SU, Smith RIF, Morrison SL. Engineering novel antibody molecules Chemical Immunology. 65: 129-158. PMID 9018876 DOI: 10.1159/000425636 |
0.47 |
|
| 1996 |
Harvill ET, Fleming JM, Morrison SL. In Vivo Properties of an IgG3-IL-2 Fusion Protein: A General Strategy for Immune Potentiation 1 Journal of Immunology. 157: 3165-3170. PMID 8816429 |
0.469 |
|
| 1996 |
Morrison S, Coloma M, Harvill E. Genetically engineered antibodies with improved functional properties Immunotechnology. 2: 69-70. DOI: 10.1016/1380-2933(96)80678-6 |
0.475 |
|
| 1995 |
Harvill ET, Morrison SL. An IgG3-IL2 fusion protein activates complement, binds FcγRI, generates LAK activity and shows enhanced binding to the high affinity IL-2R Immunotechnology. 1: 95-105. PMID 9373338 DOI: 10.1016/1380-2933(95)00009-7 |
0.512 |
|
| Show low-probability matches. |
